CIFR
Cipher Mining Inc.
There isn't enough reported data to score CIFR yet.
IBN
ICICI Bank Limited
IBN's fundamentals are mixed: its operating margin rose 1 points to 26%, but revenue fell 0.7%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
CIFR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| N/A | |
| N/A |
CIFR's revenue and profitability are currently weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like CIFR.
IBN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
IBN's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like IBN.
CIFR PE Valuation
CIFR has no meaningful PE right now: it lost money over the past year.
IBN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 18x | $30.21 | -12% |
| Fair | 19x | $32.33 | -6% |
| Expensive | 21x | $34.73 | +1% |
| Current | 21x | $34.39 | — |
Historical ranges are pointers, not guarantees.
IBN's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
CIFR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
CIFR has the edge over IBN on the outlook, with more favorable profitability expectations.
IBN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for IBN, but weaker profitability.
CIFR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.06 | -$2.86 |
| Q2 2026 | -$2.85 | -$2.40 |
| Q1 2026 | -$2.32 | -$1.94 |
| Q4 2025 | -$2.15 | -$2.01 |
| Q3 2025 | -$0.20 | -$0.07 |
| Q2 2025 | -$0.45 | -850% |
| Q1 2025 | -$0.38 | -733% |
| Q4 2024 | -$0.14 | -$0.04 |
CIFR lost $3.06 per share over the past year, and its loss has widened in each of the last four quarters.
IBN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.66 | +5.7% |
| Q1 2026 | $1.60 | +5.3% |
| Q4 2025 | $1.57 | +7.5% |
| Q3 2025 | $1.58 | +12% |
| Q2 2025 | $1.57 | +16% |
| Q1 2025 | $1.52 | +15% |
| Q4 2024 | $1.46 | +15% |
| Q3 2024 | $1.41 | +18% |
IBN has the edge over CIFR on earnings quality, reporting a profit while its opponent remains loss making.
CIFR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $26.7M | -63% |
| Q2 2026 | $24.8M | -43% |
| Q1 2026 | $34.8M | -29% |
| Q4 2025 | $59.7M | +41% |
| Q3 2025 | $71.7M | +198% |
| Q2 2025 | $43.6M | +18% |
| Q1 2025 | $49M | +1.7% |
| Q4 2024 | $42.2M | -2.8% |
CIFR's revenue has slid since its 2025 peak: $27M last quarter, down 63% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -269% | -217 points |
| Q2 2026 | -316% | -212 points |
| Q1 2026 | -329% | -251 points |
| Q4 2025 | -503% | -544 points |
| Q3 2025 | -52% | +327 points |
| Q2 2025 | -104% | -60 points |
| Q1 2025 | -78% | -175 points |
| Q4 2024 | 40% | +4 points |
CIFR's operating margin was −269% last quarter, down 217 points from the same quarter a year ago.
IBN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $6.6B | -18% |
| Q1 2026 | $9B | +6.1% |
| Q4 2025 | $8.3B | +3.8% |
| Q3 2025 | $8.1B | +4.4% |
| Q2 2025 | $8B | +11% |
| Q1 2025 | $8.5B | +20% |
| Q4 2024 | $8B | +25% |
| Q3 2024 | $7.8B | +27% |
IBN has the edge over CIFR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 35% | +8.6 points |
| Q1 2026 | 25% | +0.8 points |
| Q4 2025 | 23% | -1.6 points |
| Q3 2025 | 25% | -0.4 points |
| Q2 2025 | 26% | +1.2 points |
| Q1 2025 | 24% | -0.8 points |
| Q4 2024 | 25% | -1.1 points |
| Q3 2024 | 25% | -1 points |
IBN has the edge over CIFR on profitability, with a higher operating margin.
CIFR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.7B | -$1.4B |
| Q2 2026 | -$653.8M | -$566.3M |
| Q1 2026 | -$462.5M | -$390.7M |
| Q4 2025 | -$280.3M | -$204.2M |
| Q3 2025 | -$256.2M | -$173.1M |
| Q2 2025 | -$87.5M | -$54.3M |
| Q1 2025 | -$71.8M | -$37.3M |
| Q4 2024 | -$76.1M | +$38M |
CIFR has the edge over IBN on cash flow, with more consistent year-over-year improvement.
IBN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
IBN's free cash flow was $0 over the past year, against $0 the year before. Free cash flow isn't a meaningful measure for financial services companies like IBN.
CIFR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.4% | +30.3M shares |
| 1 year | +12% | +46.5M shares |
| 3 years | +75% | +188M shares |
| 5 years | +102% | +222M shares |
CIFR has 440M diluted shares, up 12% from a year ago, despite $151M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7M |
| Q2 2026 | $45.2M |
| Q1 2026 | $3.8M |
| Q4 2025 | $82.3M |
| Q3 2025 | $3M |
| Q2 2025 | $3.2M |
| Q1 2025 | $1.1M |
| Q4 2024 | $16.9M |
CIFR spent $151M buying back its own shares over the past year, about six times what it spent the year before.
IBN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +2.6M shares |
| 1 year | +0.1% | +3M shares |
| 3 years | +1.7% | +59.4M shares |
| 5 years | +2.6% | +92.9M shares |
| Available history | +7.5% | +254M shares |
IBN has the edge over CIFR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
IBN hasn't bought back shares in the past year.
CIFR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -2.3x | Net Cash |
| Q1 2025 | 125.4x | High |
| Q4 2024 | 0.5x | Very low |
| Q3 2024 | -0.7x | Net Cash |
| Q2 2024 | -1.2x | Net Cash |
| Q1 2024 | -0.9x | Net Cash |
| Q4 2023 | -2.2x | Net Cash |
| Q2 2023 | -0.1x | Net Cash |
CIFR has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like CIFR.
IBN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | 0.8x | Very low |
IBN's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like IBN.
CIFR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.4 | Neutral |
| Stochastic | 7.8 | Oversold |
CIFR's weekly RSI is 34 (neutral) and its Stochastic is 8 (oversold).
IBN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.0 | Overbought |
| Stochastic | 85.3 | Overbought |
IBN's weekly RSI is 71 (overbought) and its Stochastic is 85 (overbought).
CIFR PE vs Financial Services Sector
| Metric | CIFR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
CIFR has no meaningful PE right now: it lost money over the past year.
IBN PE vs Financial Services Sector
| Metric | IBN | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 13x | 60% above |
| PE % | 79 | 63 | 16 pts above |
IBN is trading at 21x earnings, a 60% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
CIFR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.6 | 33% below |
| 20 week MA | $15.5 | 54% below |
| 50 week MA | $17.0 | 58% below |
| 100 week MA | $12.2 | 41% below |
| 200 week MA | $7.86 | 9% below |
CIFR is in a downtrend: it's below all five of its weekly moving averages, and 9% below its 200-week average.
IBN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.1 | 14% above |
| 20 week MA | $29.8 | 15% above |
| 50 week MA | $29.0 | 19% above |
| 100 week MA | $30.2 | 14% above |
| 200 week MA | $27.7 | 24% above |
IBN has the edge over CIFR on trend strength, trading above more of its moving averages.
CIFR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.92 | $9.95 | +0.3% |
| 2021 | $9.95 | $5.21 | -48% |
| 2022 | $5.21 | $0.54 | -90% |
| 2023 | $0.54 | $4.13 | +665% |
| 2024 | $4.13 | $4.86 | +18% |
| 2025 | $4.86 | $15.2 | +213% |
| 2026 YTD | $15.2 | $7.15 | -53% |
CIFR's yearly returns have swung widely, from +665% in 2023 to −90% in 2022. It's down 53% so far in 2026.
IBN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.3 | $14.0 | -8.4% |
| 2021 | $14.0 | $19.3 | +38% |
| 2022 | $19.3 | $21.6 | +12% |
| 2023 | $21.6 | $23.8 | +11% |
| 2024 | $23.8 | $30.5 | +28% |
| 2025 | $30.5 | $30.1 | -1.3% |
| 2026 YTD | $30.1 | $34.4 | +14% |
IBN has the edge over CIFR on returns for 2026, with the stronger performance.